Ligand validation:6S75

F9N: 3-[[6-(cyclohexylmethoxy)-7~{H}-purin-2-yl]amino]-~{N}-[3-(dimethylamino)propyl]benzenesulfonamide

F9N is a Ligand Of Interest in 6S75 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S75_F9N_C_401	16%	7%	0.283	0.851	2.11	2.91	8	13	0	0	100%	1
6S75_F9N_B_401	7%	6%	0.384	0.837	2.17	2.97	8	14	1	0	100%	1
6S75_F9N_A_401	6%	6%	0.395	0.82	2.24	3.12	8	14	0	0	100%	1
6S73_F9N_C_401	19%	6%	0.258	0.85	2.2	2.96	8	11	1	0	100%	1
6SK9_F9N_A_301	61%	3%	0.149	0.939	2.48	3.92	8	17	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.